Here’s the state of prostate cancer, according to a new Lancet Commission on Prostate Cancer report just published on April 4 in The Lancet. It’s already the most common cancer among men in 112 ...

Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...

A recent study by the Lancet Commission that was presented at the European Association of Urology meeting in Paris, revealed that the number of prostate cancer cases is to double by 2040 and is ...

In the FUTURE 2 study, secukinumab demonstrated rapid onset of action, was significantly superior to placebo in improving signs and symptoms of psoriatic arthritis (PsA), with efficacy sustained over ...

Screening for prostate cancer could reduce deaths from the disease by about a fifth, according to the long-term results of a major European study involving over 162 000 men published in The Lancet.

The Lancet study, conducted in Europe, found a survival benefit with early diagnosis, but does not agree that the benefit outweighs some of the associated risks of the test. The value of the PSA test ...